McCann Wins $50 Mil. Lotrel Biz

McCann-Erickson has won a review for creative duties on the estimated $50 million account of Novartis’ Lotrel hypertension medicine, sources said. The IPG shop bested sibling Deutsch and WPP’s Ogilvy & Mather, both in New York, and The Quantum Group in Parsippany, N.J. Novartis has advertised the drug to medical professionals but now wants to target consumers, sources said.

Agency executives referred calls to client officials, who could not be reached.